
Factory supply good quality (-)-SPARTEINE 90-39-1 with stock
- Molecular Formula:C15H26N2
- Molecular Weight:234.385
- Vapor Pressure:0mmHg at 25°C
- Melting Point:30.5°C
- Refractive Index:n20/D 1.528(lit.)
- Boiling Point:340.9 °C at 760 mmHg
- PKA:2.24, 9.46(at 20℃)
- Flash Point:148.3 °C
- PSA:6.48000
- Density:1.08 g/cm3
- LogP:2.22090
(-)-SPARTEINE(Cas 90-39-1) Usage
|
Health Hazard |
Toxic actions of sparteine are similar to thoseof coniine but are much less toxic than thoseof coniine. The toxic symptoms in mice weretremor, muscle contraction, and respiratorydistress. An intraperitoneal dose lethal toguinea pigs is 23 mg/kg.LD50 value, oral (mice): 220 mg/kg. |
InChI:InChI=1/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m1/s1
90-39-1 Relevant articles
ALKALOID DISTRIBUTION IN SOME SPECIES OF THE PAPILIONACEOUS TRIBES SOPHOREAE, DALBERGIEAE, LOTEAE, BRONGNIARTIEAE AND BOSSIAEEAE
Kinghorn, A. Douglas,Balandrin, Manuel F.,Lin, Lee-Juian
, p. 2269 - 2276 (1982)
Quinolizidine and dipiperidine alkaloid ...
Gram-Scale Synthesis of the (?)-Sparteine Surrogate and (?)-Sparteine
Firth, James D.,Canipa, Steven J.,Ferris, Leigh,O'Brien, Peter
, p. 223 - 226 (2017/12/29)
An 8-step, gram-scale synthesis of the (...
The Enantioselective Total Synthesis of Bisquinolizidine Alkaloids: A Modular “Inside-Out” Approach
Scharnagel, Dagmar,Goller, Jessica,Deibl, Nicklas,Milius, Wolfgang,Breuning, Matthias
supporting information, p. 2432 - 2435 (2018/02/16)
Bisquinolizidine alkaloids are character...
A Two-Directional Synthesis of (+)-β-Isosparteine
Al-Saffar, Firas M.,Brown, Richard C. D.
supporting information, p. 3502 - 3504 (2017/07/15)
A two-directional synthesis of (+)-β-iso...
PROCESS FOR CONVERTING LUPANINE INTO SPARTEINE
-
Page/Page column 6; 7, (2014/12/12)
The present invention relates to process...
90-39-1 Process route
-
-
72074-77-2,908836-10-2
d,l-lupanine
-
-
90-39-1,446-95-7,492-06-8,492-08-0,4985-24-4,6838-37-5,6917-37-9,24915-04-6,88269-31-2
sparteine
| Conditions | Yield |
|---|---|
|
With
sodium tetrahydroborate; iodine;
In
tetrahydrofuran;
at 80 ℃;
for 16h;
Reagent/catalyst;
Solvent;
Temperature;
Time;
Concentration;
|
90% |
-
-
90-39-1,446-95-7,492-06-8,492-08-0,4985-24-4,6838-37-5,6917-37-9,24915-04-6,88269-31-2
sparteine
| Conditions | Yield |
|---|---|
|
Aphyllicacid, H2;
|
|
|
α-Isolupaninperchlorat, LiAlH4 (Ae.,Δ);
|
|
|
(-)-Lupamin, Diboran (THF);
|
|
|
Bea. Behandeln von δ1(6)-Dehydro-sparteinium-(diperchlorat), Tetrahydrofuran,NaBH4, BF3-aserat;
|
|
|
Isol. aus Sophora pachycarpa;
|
|
|
Biosynthese;
|
|
|
Zur Trennung v. anderen Lupinenalkaloiden durch Papierelektrophorese;
|
|
|
Chelidonium Majus;
|
|
|
(17,17-D2)-Spartein: 17-Oxo-spartein, LiAlD4 (S. 5455);
|
|
|
(10,10-D2)-Spartein: Aphyllin, LiAlD4 (S. 5455);
|
|
|
(6β,17,17-D3)-Spartein: (17,17-D2)-5,6-Dehydro-spratein, NaBD4 (S. 5455);
|
|
|
(2,2-D2)-Spartein: Lupanin, LiAlD4 (S. 5455);
|
|
|
(6β-D)-Spartein: 5,6-Dehydro-spartein, NaBD4;
|
|
|
(2,2,6β-D3)-Spartein: (2,2-D2)-5,6-Dehydro-spartein, NaBD4;
|
|
|
(2,2,6β,17,17-D5)-Spartein: (2,2,17,17-D4)-5,6-Dehydro-spartein, NaBD4 (S. 5455);
|
|
|
(2,217,17-D4)-Spartein: 17-Oxo-Lupanin, LiAlD4 (S. 5455);
|
|
|
(15,15-D2)-Spartein: α-Isolupanin, LiAlD4 (S. 5455);
|
|
|
1-Chlormethyl-3-
|
90-39-1 Upstream products
-
90-39-1
(+-)-sparteine
-
550-90-3
(+)-lupanine
-
489-54-3
(1R,2R,9S,10S)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane-8,16-dione
-
773070-58-9
ethyl {(2S)-1-[(1R)-1-phenylethyl]piperidin-2-yl}acetate
90-39-1 Downstream products
-
489-72-5
(-)-17-oxosparteine
-
477-22-5
(7S,7'R)-(7at,7'ac',14'at')-Δ1(14a)-docosahydro-7r,14c;7'r',14'c'-dimethano-[1,6'ξ]bi[dipyrido[1,2-a;1',2'-e][1,5]diazocinyl]
-
2130-67-8
5,6-Didehydrosparteine
-
489-72-5
17-oxosparteine
